日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Osimertinib for lung cancer cells harboring low-frequency EGFR T790M mutation.

奥希替尼用于治疗携带低频 EGFR T790M 突变的肺癌细胞

Joshi Asim, Butle Ashwin, Hait Supriya, Mishra Rohit, Trivedi Vaishakhi, Thorat Rahul, Choughule Anuradha, Noronha Vanita, Prabhash Kumar, Dutt Amit

Weekly osimertinib dosing prevents EGFR mutant tumor cells destined to home mouse lungs

每周一次的奥希替尼给药可阻止EGFR突变肿瘤细胞转移至小鼠肺部。

Butle, Ashwin; Joshi, Asim; Noronha, Vanita; Prabhash, Kumar; Dutt, Amit